Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 5, 2011, Pages 1016-1023

  Liao, Mingmin ^a,b   Gu, Wei Ming ^c   Yang, Yang ^c   Dillon, Jo Anne R ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c Shanghai Skin Disease and STD Hospital   (China)

Author keywords

Antimicrobial resistance; MtrR; PenA; PonA; PorB; Third generation cephalosporins

Indexed keywords

CEFTRIAXONE;

ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; DIMERIZATION; DNA BINDING; DNA SEQUENCE; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MTRR GENE; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PBP1 GENE; PHENOTYPE; PORB GENE; UNINDEXED SEQUENCE; WILD TYPE;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; CEFTRIAXONE; CHINA; DNA, BACTERIAL; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEISSERIA GONORRHOEAE; PENICILLIN-BINDING PROTEINS; PORINS; REPRESSOR PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 79954569209     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr021     Document Type: Article

References (40)

1. Tapsall JW. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther 2006; 4: 619-28.
2. Tapsall JW. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr Opin Infect Dis 2009; 22: 87-91.
3. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother 2009; 10: 555-77.
4. Deguchi T, Yasuda M, Yokoi S et al. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J Infect Chemother 2003; 9: 35-9.
5. Lo JY, Ho KM, Leung AO et al. Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection. Antimicrob Agents Chemother 2008; 52: 3564-7.
6. Yokoi S, Deguchi T, Ozawa T et al. Threat to cefixime treatment for gonorrhea. Emerg Infect Dis 2007; 13: 1275-7.
7. Tanaka M, Nakayama H, Huruya K et al. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int J Antimicrob Agents 2006; 27: 20-6.
8. Spratt BG. Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae. Nature 1988; 332: 173-6.
9. Ameyama S, Onodera S, Takahata M et al. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother 2002; 46: 3744-9.
10. Ito M, Deguchi T, Mizutani K et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother 2005; 49: 137-43.
11. Takahata S, Senju N, Osaki Y et al. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 2006; 50: 3638-45.
12. Osaka K, Takakura T, Narukawa K et al. Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J Infect Chemother 2008; 14: 195-203.
13. Ropp P, Hu M, Olesky M et al. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 769-77.
14. Shigemura K, Shirakawa T, Massi N et al. Presence of a mutation in ponA1 of Neisseria gonorrhoeae in numerous clinical samples resistant to various beta-lactams and other, structurally unrelated, antimicrobials. J Infect Chemother 2005; 11: 226-30.
15. Lee SG, Lee H, Jeong SH et al. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. J Antimicrob Chemother 2010; 64: 669-75.
16. Hagman K, Pan W, Spratt B et al. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the MtrRCDE efflux system. Microbiol 1995; 141: 611-22.
17. Hagman K, Shafer W. Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae. J Bacteriol 1995; 177: 4162-5.
18. Lucas C, Balthazar J, Hagman K et al. The MtrR repressor binds the DNA sequence between the mtrR and mtrC genes of Neisseria gonorrhoeae. J Bacteriol 1997; 179: 4123-8.
19. Shafer WM, Balthazar JT, Hagman KE et al. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiol 1995; 141: 907-11.
20. Xia M, Whittington W, Shafer W et al. Gonorrhea among men who have sex with men: outbreak caused by a single genotype of erythromycin-resistant Neisseria gonorrhoeae with a single-base pair deletion in the mtrR promoter region. J Infect Dis 2000; 181: 2080-2.
21. Danielsson D, Faruki H, Dyer D et al. Recombination near the antibiotic resistance locus penB results in antigenic variation of gonococcal outer membrane protein I. Infect Immun 1986; 52: 529-33.
22. Scudamore R, Beveridge T, Goldner M. Penetrability of the outer membrane of Neisseria gonorrhoeae in relation to acquired resistance to penicillin and other antibiotics. Antimicrob Agents Chemother 1979; 15: 820-7.
23. Gotschlich EC, Seiff ME, Blake MS et al. Porin protein of Neisseria gonorrhoeae: cloning and gene structure. Proc Natl Acad Sci USA 1987; 84: 8135-9.
24. Unemo M, Olcén P, Berglund T et al. Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains. J Clin Microbiol 2002; 40: 3741-9.
25. Liao M, Bell K, Gu Wet al. Clusters of circulating Neisseria gonorrhoeae strains and association with antimicrobial resistance in Shanghai. J Antimicrob Chemother 2008; 61: 478-87.
26. Gill MJ, Simjee S, Al-Hattawi K et al. Gonococcal resistance to b-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus. Antimicrob Agents Chemother 1998; 42: 2799-803.
27. Olesky M, Hobbs M, Nicholas R. Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 2811-20.
28. Olesky M, Zhao S, Rosenberg R et al. Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB proteins with penB mutations. J Bacteriol 2006; 188: 2300-8.
29. Zhao S, Duncan M, Tomberg J et al. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2009; 53: 3744-51.
30. Yang Y, Liao M, Gu Wet al. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai. J Antimicrob Chemother 2006; 58: 868-72.
31. Martin IM, Ison CA, Aanensen DM et al. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis 2004; 189: 1497-505.
32. Liao M, Helgeson S, Gu WM et al. Comparison of Neisseria gonorrhoeae multiantigen sequence typing and porB sequence analysis for identification of clusters of N. gonorrhoeae isolates. J Clin Microbiol 2009; 47: 489-91.
33. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Information Supplement M100-S16. CLSI, Wayne, PA, USA, 2006.
34. Ochiai S, Sekiguchi S, Hayashi A et al. Decreased affinity of mosaic-structure recombinant penicillin-binding protein 2 for oral cephalosporins in Neisseria gonorrhoeae. J Antimicrob Chemother 2007; 60: 54-60.
35. Ropp PA, Nicholas RA. Cloning and characterization of the ponA gene encoding penicillin-binding protein 1 from Neisseria gonorrhoeae and Neisseria meningitidis. J Bacteriol 1997; 179: 2783-7.
36. Yates F. Contingency tables involving small numbers and the x2 test. J Roy Stat Soc 1934; 1: 217-35.
37. Lindberg R, Fredlund H, Nicholas R et al. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother 2007; 51: 2117-22.
38. Whiley DM, Limnios EA, Ray S et al. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 2007; 51: 3111-6.
39. Whiley DM, Goire N, Lambert SB et al. Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J Antimicrob Chemother 2010; 65: 1615-8.
40. Hoffmann K, Williams D, Shafer W et al. Characterization of the multiple transferable resistance repressor, MtrR, from Neisseria gonorrhoeae. J Bacteriol 2005; 187: 5008-12.